Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells

O Fedorchuk, Y Susak, M Rudyk, N Senchylo… - Cancer Chemotherapy …, 2018 - Springer
Purpose Tumor cell resistance to platinum-based chemotherapeutic agents is one of the
major hurdles to successful cancer treatment with these drugs, and is associated with …
被引用次数：6 相关文章

Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells

O Fedorchuk, Y Susak, M Rudyk… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose Tumor cell resistance to platinum-based chemotherapeutic agents is one of the
major hurdles to successful cancer treatment with these drugs, and is associated with …

Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells

O Fedorchuk, Y Susak, M Rudyk, N Senchylo… - Cancer Chemotherapy …, 2018 - elibrary.ru
Purpose: Tumor cell resistance to platinum-based chemotherapeutic agents is one of the
major hurdles to successful cancer treatment with these drugs, and is associated with …

Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells

O Fedorchuk, Y Susak, M Rudyk… - Cancer …, 2018 - search.proquest.com
Purpose Tumor cell resistance to platinum-based chemotherapeutic agents is one of the
major hurdles to successful cancer treatment with these drugs, and is associated with …

Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.

O Fedorchuk, Y Susak, M Rudyk… - Cancer …, 2017 - europepmc.org
Purpose Tumor cell resistance to platinum-based chemotherapeutic agents is one of the
major hurdles to successful cancer treatment with these drugs, and is associated with …